Prognosis Research Strategy (PROGRESS) 3: prognostic model research.
Ewout W Steyerberg;
Karel GM Moons;
Danielle A van der Windt;
Jill A Hayden;
Pablo Perel 
;
Sara Schroter;
Richard D Riley;
Harry Hemingway;
Douglas G Altman;
PROGRESS Group;
(2013)
Prognosis Research Strategy (PROGRESS) 3: prognostic model research.
PLoS medicine, 10 (2).
e1001381-.
ISSN 1549-1277
DOI: 10.1371/journal.pmed.1001381
;
Sara Schroter;
Richard D Riley;
Harry Hemingway;
Douglas G Altman;
PROGRESS Group;
(2013)
Prognosis Research Strategy (PROGRESS) 3: prognostic model research.
PLoS medicine, 10 (2).
e1001381-.
ISSN 1549-1277
DOI: 10.1371/journal.pmed.1001381
Prognostic models are abundant in the medical literature yet their use in practice seems limited. In this article, the third in the PROGRESS series, the authors review how such models are developed and validated, and then address how prognostic models are assessed for their impact on practice and patient outcomes, illustrating these ideas with examples.
-
picture_as_pdf - Prognosis Research Strategy (PROGRESS) 3_GOLD VoR.PDF
-
subject - Published Version
-
- Available under Creative Commons: 3.0
Downloads